Eton Pharmaceuticals launches U.S. commercial availability of IMPAVIDO with patient support

Eton Pharmaceuticals launched U.S. commercial availability of IMPAVIDO (miltefosine) capsules and integrated Eton Cares patient support including $0 co-pay for eligible commercially insured patients.Key Highlights:Original SEC Filing: Eton Pharmaceuticals, Inc. [ ETON ] - 8-K - Sep. 28, 2026This is…